The Read Out Loud
Summary
The Read Out Loud is hosted by Allison DeAngelis, Adam Feuerstein, Elaine Chen covering Biotech Investing, Biotech Stocks, XBI Index, and Obesity Drugs. Episodes span from Dec 2023 to Jan 2026.
Novo Nordisk's new CEO, Mike DuStar, discusses his strategy to compete with Eli Lilly in the obesity market, emphasizing the company's history of organic growth, a disciplined M&A approach, and a n...
The biotech sector, measured by the XBI index, experienced a significant rally in early 2024, driven by company-specific positive data rather than broader macroeconomic trends. The market for obesi...
The Federal Trade Commission (FTC) is taking a more aggressive antitrust stance, moving to block a Sanofi-Maize Therapeutics licensing deal, which signals heightened scrutiny for the biotech indust...